DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 990 filers reported holding DANAHER CORPORATION in Q3 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,000 | -25.0% | 11 | 0.0% | 0.00% | – |
Q4 2021 | $4,000 | -98.5% | 11 | -99.7% | 0.00% | -100.0% |
Q3 2016 | $275,000 | -22.3% | 3,507 | 0.0% | 0.03% | -17.6% |
Q2 2016 | $354,000 | +4.4% | 3,507 | -1.8% | 0.03% | 0.0% |
Q1 2016 | $339,000 | +4.6% | 3,573 | +2.4% | 0.03% | 0.0% |
Q4 2015 | $324,000 | -43.9% | 3,489 | -48.6% | 0.03% | +13.3% |
Q3 2015 | $578,000 | +98.6% | 6,792 | +100.0% | 0.03% | +11.1% |
Q2 2015 | $291,000 | +9.0% | 3,396 | +8.2% | 0.03% | 0.0% |
Q1 2015 | $267,000 | -6.6% | 3,140 | -6.0% | 0.03% | -6.9% |
Q4 2014 | $286,000 | +12.6% | 3,339 | 0.0% | 0.03% | +7.4% |
Q3 2014 | $254,000 | +2.0% | 3,339 | +5.4% | 0.03% | +12.5% |
Q2 2014 | $249,000 | -99.9% | 3,167 | 0.0% | 0.02% | -4.0% |
Q1 2014 | $237,525,000 | -2.8% | 3,167 | 0.0% | 0.02% | -3.8% |
Q4 2013 | $244,492,000 | +11.4% | 3,167 | 0.0% | 0.03% | +4.0% |
Q3 2013 | $219,536,000 | +109668.0% | 3,167 | 0.0% | 0.02% | 0.0% |
Q2 2013 | $200,000 | – | 3,167 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |